We are live on ! Find out more
MG

Marex Group Portfolio holdings

AUM $15.8B
1-Year Est. Return 31.44%
This Fund
S&P 500
This Quarter Est. Return
-10.64%
1 Year Est. Return
+31.44%
3 Year Est. Return
+143.62%
5 Year Est. Return
10 Year Est. Return
AUM
$15.9B
AUM Growth
+$1.74B
Cap. Flow
+$3.32B
Cap. Flow %
20.89%
Top 10 Hldgs %
25.45%
Holding
1,202
New
361
Increased
299
Reduced
251
Closed
239

Top Buys

Rank Stock Value
1
BMNR
BitMine Immersion Technologies
BMNR
+$345M
2
AVGO icon
Broadcom
AVGO
+$265M
3
IREN icon
Iris Energy
IREN
+$230M
4
TSLA icon
Tesla
TSLA
+$215M
5
ORCL icon
Oracle
ORCL
+$210M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$324M
2
BKNG icon
Booking.com
BKNG
+$162M
3
MA icon
Mastercard
MA
+$89.6M
4
NOW icon
ServiceNow
NOW
+$60.5M
5
NFLX icon
Netflix
NFLX
+$59.9M

Sector Composition

Rank Sector Weight
1 Technology 18.87%
2 Financials 9.37%
3 Consumer Discretionary 6.21%
4 Communication Services 5.85%
5 Healthcare 5.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RIV.RT
1201
DELISTED
RiverNorth Opportunities Fund Rights
RIV.RT
-15,071
Closed -$122
UTF.RT
1202
DELISTED
Cohen & Steers Infrastructure Fund Rights exp Oct 16 2025
UTF.RT
-480,104
Closed -$37.4K

Similar funds

Marex Group's Q4 2025 Portfolio in Review

As of Q4 2025, Marex Group held 1,202 positions worth $15.9B, up 12% from $14.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Marex Group deployed $3.32B of net new capital in Q4 2025, opening 361 new positions and adding to 299 existing holdings. Its largest new stake was AdvisorShares Pure US Cannabis ETF: 6,900,000 shares worth $32.6M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Eli Lilly, an estimated $324M trimmed.

  • Marex Group's largest Q4 2025 buy was AdvisorShares Pure US Cannabis ETF: 6,900,000 shares worth $32.6M.
  • Marex Group added most to BitMine Immersion Technologies in Q4 2025, an estimated $345M increase.
  • Marex Group's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $324M.
  • Marex Group fully exited S&P Global in Q4 2025, selling an estimated $48.8M.
  • Marex Group's ten largest holdings make up 25% of its $15.9B portfolio in Q4 2025.
  • Marex Group opened 361 new positions and closed 239 in Q4 2025.
  • Marex Group's portfolio value rose 12% quarter-over-quarter to $15.9B.

Based on Marex Group's 13F filing for Q4 2025, filed 12 Feb 2026.